CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy. Founded by Will West in 2003, CellCentric is backed by Innovate UK, Morningside Venture Investments, 5Y Capital, Takeda Ventures, Inc., and Morningside Venture Partners and is headquartered in Cambridge.
FOUNDED:
2003
INDUSTRY:
Biotechnology, Medical, Therapeutics
FOUNDERS:
Will West
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
